Tian Xia

1.9k total citations
50 papers, 1.3k citations indexed

About

Tian Xia is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Tian Xia has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 9 papers in Reproductive Medicine. Recurrent topics in Tian Xia's work include Pulmonary Hypertension Research and Treatments (12 papers), Ovarian function and disorders (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Tian Xia is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Ovarian function and disorders (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Tian Xia collaborates with scholars based in China, Germany and United States. Tian Xia's co-authors include Ralph T. Schermuly, Werner Seeger, Norbert Weißmann, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Baktybek Kojonazarov, Ke Lan, Soni Savai Pullamsetti, Deguang Liang and Walter Klepetko and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Tian Xia

44 papers receiving 1.3k citations

Peers

Tian Xia
Tian Xia
Citations per year, relative to Tian Xia Tian Xia (= 1×) peers Xinxin Zhang

Countries citing papers authored by Tian Xia

Since Specialization
Citations

This map shows the geographic impact of Tian Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Xia more than expected).

Fields of papers citing papers by Tian Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Xia. The network helps show where Tian Xia may publish in the future.

Co-authorship network of co-authors of Tian Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Tian Xia. A scholar is included among the top collaborators of Tian Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian Xia. Tian Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Chen, Xiang Ji, Yansong Liu, et al.. (2025). E3 ligase TRIM22 promotes melanoma proliferation by regulating cell cycle progression through K63-linked ubiquitination of p21. Scientific Reports. 15(1). 22311–22311.
2.
He, Zhiwei, Yiming Wang, Tian Xia, et al.. (2024). R-Judge: Benchmarking Safety Risk Awareness for LLM Agents. 1467–1490. 11 indexed citations
3.
Jiang, Hongyi, Tian Xia, Liting Jiang, et al.. (2024). Chemotactic recruitment of genetically engineered cell membrane-camouflaged metal−organic framework nanoparticles for ischemic osteonecrosis treatment. Acta Biomaterialia. 185. 410–428. 6 indexed citations
4.
Xia, Tian, Yongkang Zhang, Dong Yang, et al.. (2024). EVA1B facilitates esophageal squamous carcinoma progression and recruitment of immunosuppressive myeloid-derived suppressor cells in the tumor microenvironment. Pharmacological Research. 210. 107521–107521. 9 indexed citations
5.
Xia, Tian, Yuting Zhu, Kaiqiang Li, et al.. (2024). Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis. Journal of Nanobiotechnology. 22(1). 103–103. 28 indexed citations
6.
Chen, Zhenghong, Lu Zhang, Liyuan Wang, et al.. (2023). Aloe-emodin destroys the biofilm of Helicobacter pylori by targeting the outer membrane protein 6. Microbiological Research. 278. 127539–127539. 11 indexed citations
7.
Xia, Tian, Xiaoyu Ren, Li He, et al.. (2023). NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway. Nature Communications. 14(1). 8440–8440. 6 indexed citations
8.
Wang, Weili, Huizhen Zheng, Jun Jiang, et al.. (2022). Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments. Nature Communications. 13(1). 4495–4495. 55 indexed citations
9.
Dahan, Jennifer, Florence Levillayer, Tian Xia, et al.. (2017). LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β 1 Expression. Molecular and Cellular Biology. 37(10). 17 indexed citations
10.
Kojonazarov, Baktybek, Tatyana Novoyatleva, Mario Boehm, et al.. (2017). p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy. American Journal of Respiratory Cell and Molecular Biology. 57(5). 603–614. 85 indexed citations
11.
Budas, Grant R., Mario Boehm, Baktybek Kojonazarov, et al.. (2017). ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 197(3). 373–385. 77 indexed citations
12.
Xia, Tian, Shuang Li, Jiacui Li, et al.. (2017). Effects of liver depression and psychological stress on human uterine leiomyoma cells by an AR–cAMP–PKA signal transduction pathway. Taiwanese Journal of Obstetrics and Gynecology. 56(3). 291–301. 6 indexed citations
13.
Sydykov, Akylbek, Tian Xia, Argen Mamazhakypov, et al.. (2016). Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice. International Journal of Cardiology. 216. 85–91. 27 indexed citations
14.
Sibinska, Zaneta, Tian Xia, Martina Korfei, et al.. (2016). Amplified canonical transforming growth factor-β signallingviaheat shock protein 90 in pulmonary fibrosis. European Respiratory Journal. 49(2). 1501941–1501941. 66 indexed citations
15.
Dabral, Swati, Tian Xia, Baktybek Kojonazarov, et al.. (2016). Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension. European Respiratory Journal. 48(4). 1137–1149. 81 indexed citations
16.
Xia, Tian, et al.. (2014). Recovery of ovary function impaired by chemotherapy using Chinese herbal medicine in a rat model. Systems Biology in Reproductive Medicine. 60(5). 293–303. 11 indexed citations
17.
Lang, Michaela, Baktybek Kojonazarov, Tian Xia, et al.. (2012). The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats. PLoS ONE. 7(8). e43433–e43433. 97 indexed citations
18.
Xia, Tian, Laurence Lévy, Florence Levillayer, et al.. (2012). The Four and a Half LIM-only Protein 2 (FHL2) Activates Transforming Growth Factor β (TGF-β) Signaling by Regulating Ubiquitination of the E3 Ligase Arkadia. Journal of Biological Chemistry. 288(3). 1785–1794. 26 indexed citations
19.
Liu, Yunhua, Deguang Liang, Yuan Gao, et al.. (2008). Kaposi’s sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jκ and a cis-acting RTA responsive element. Virology. 380(2). 264–275. 33 indexed citations
20.
Labalette, Charlotte, Yann Nouët, Florence Levillayer, et al.. (2008). The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways. PLoS ONE. 3(11). e3761–e3761. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026